Response to Letter to the Editor on “Clinical Features and Surgical Outcomes of Patients With Moyamoya Disease and the Homozygous RNF213 p.R4810 K Variant”
Restricted accessLetterFirst published online August, 2020
Response to Letter to the Editor on “Clinical Features and Surgical Outcomes of Patients With Moyamoya Disease and the Homozygous RNF213 p.R4810 K Variant”
ZhangQGePMaY, et al.Clinical features and surgical outcomes of patients with moyamoya disease and the homozygous Rnf213 P.R4810 k variant. J Child Neurol. 2019;34(13):793–800.
2.
AppireddyRRanjanMDurafourtBARiva-CambrinJHaderWJAdelsonPD. Surgery for moyamoya disease in children. J Child Neurol. 2019;34(9):517–529.
3.
HaEJKimKHWangKC, et al.Long-term outcomes of indirect bypass for 629 children with moyamoya disease: longitudinal and cross-sectional analysis. Stroke. 2019;50(11):3177–3183.
4.
LanternaLA. Moyamoya disease: from hypoperfusion to network disruption. World Neurosurg. 2017;104:1036–1037.
5.
ZhangQLiuYZhangD, et al.Rnf213 as the major susceptibility gene for chinese patients with moyamoya disease and its clinical relevance. J Neurosurg. 2017;126(4):1106–1113.
